Purpose: Previous studies have suggested that placebo injections into the knee joint can relieve pain in patients with knee osteoarthritis (KOA). It is now clear that several different types of pain and pain mechanisms can occur in KOA: some patients have significant pain sensitisation, and a generalised pain problem complicating any peripheral, nocioceptive cause. It is also known that some 20% of people who have a knee replacement do not obtain good pain relief. We wanted to investigate the possible value of an intraarticular injection of either a placebo or a local anaesthetic as an aid to sorting out pain mechanisms, and helping patients and their doctors decide whether surgery might be a good treatment option. Methods: The study was approved by the local ethics committee. 20 patients attending a rheumatology clinic because of bilateral, painful KOA were recruited and gave signed, informed consent. Demographic data was collected, including a full pain history, and the knees were examined. Each patient then had two injections into the knee which was causing them most pain (the index knee), with an interval of two weeks between each injection. They were randomised to having intraarticular Marcaine or an equivalent volume of saline first, and the alternative injection second, in a double blind study design. Prior to each injection pain questionnaires were administered, including the s-LANSS to assess neuropathic pain, and the HADs to assess the degree of anxiety and depression. Following each injection pain scores were collected daily in relation to both knees, for a two week period. 3 months after the end of the study all patients were recalled for followup at which point they were asked about their satisfaction with being in the study, their preference for the first or second injection, the overall amount of symptom relief, whether the contralateral knee had improved during the study, and whether being in the study had helped them understand their pain better and decide whether surgery was for them or not. Results: 13 women and 7 men were recruited to the study, 14 were Caucasian, 4 Indian and 2 Samoan, their mean age was 63 years (range 47-81). All were on some medication for their painful knee OA (18 simple analgesics, 14 NSAIDs) and they were suffering from a variety of co-morbidities. Baseline scores indicated that 7 were complaining of widespread pain problems in addition to knee pain, 4 had s-LANSS scores of 12 or greater indicative of neuropathic-like pain, and 3 had a high HADs score indicative of significant anxiety/depression. 10 patients had Marcaine first and 10 Saline first. Most patients reported some pain relief after each injection, but there were no significant differences in pain scores after the Marcaine or Saline: pain relief was greater after Marcaine than Saline in 7 people, greater after Saline than Marcaine in 8, and in the remaining 5 the pain relief scores were almost identical after each injection. The total pain scores at the end of each two week observation period showed that scores were lower at the end of the second period than at the end of the first, irrespective of whether Marcaine or Saline was injected first, and at the three month assessment 13 said they favoured the second injection and 7 the first. Four patients reported improvement in pain in the contralateral knee. There was no apparent difference in the response to Saline or Marcaine in those with or without widespread pain, neuropathic pain, or anxiety/ depression. However, satisfaction with the study did differ in these groups: fewer of those with widespread pain, neuropathic pain and anxiety or depression reported that they got better than those without any such features (5 of 9 compared with 9 of 11 respectively). 19 or the 20 said they were pleased to have had the chance to take part, 13 said that it had helped greatly with their understanding of their pain problem and 9 said it had influenced their decision about surgical intervention. Conclusions: There was very little difference in the pain response to intra-articular Marcaine or Saline in this small pilot placebo study of intra-articular injections in patients with KOA. This suggests that much of the response to any intra-articular therapy is placebo related. The study is too small to reach any conclusions about the value of this approach in sorting out different pain syndromes, but we believe it likely that it could be a helpful research tool, and out data strongly suggest that it can be a valuable aid to doctors and patients in gaining understanding of the pain, and in coming to appropriate treatment decisions. Purpose: Curcuminoids are natural products with potent anti-inflammatory and antioxidant properties. There have been a number of reports on the analgesic effects of curcuminoids in clinical trials, yet data have not been fully conclusive. The objective of this study was to provide the highest level of evidence on the efficacy of curcuminoids in patients with painful conditions through meta-analysis of data from randomized controlled trials (RCTs). Methods: A systematic review and meta-analysis was conducted using data reported by RCTs. The primary efficacy measure was pain intensity or algofunctional status. Treatment effect was summarized with standardized mean difference (SMD) calculated from differences in means of pain measures between treatment and control groups using a random-effects model. Results: A total of 8 RCTs met our inclusion criteria, that included 606 randomized patients with diffrent painful conditions (osteoarthritis, rheumatoid arthritis, fibromyalgia). Curcuminoids were found to significantly reduce pain (SMD: -0.57, 95% CI: -1.11 to -0.03, p ¼ 0.04). This pain-relieving effect was found to be independent of administered dose and duration of treatment with curcuminoids, and was free from publication bias. Curcuminoids were safe and well tolerated in all evaluated RCTs. Conclusions: This meta-analysis of RCTs showed that supplementation with curcuminoids is a safe and effective strategy to reduce pain severity.
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TRADITIONAL CHINESE MEDICINE FOR OSTEOARTHRITIS PAIN: A META-ANALYSIS
B. Chen y, C. Lo z, H. Zhan y, X. Lin y, C. Wang z.
y Shuguang Hosp. affiliated to Shanghai Univ. of Traditional Chinese Med., Shanghai, China; z Tufts Med. Ctr., Boston, MA, USA Purpose: The history of oral Chinese herbal medicine is ancient, and the therapy is considered to have analgesic effects for patients with knee osteoarthritis (OA). We conducted a systematic review and metaanalysis of the evidence to evaluate the efficacy for pain relief of oral Chinese herbal medicine in patients with knee OA.
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